Package Leaflet: Information for the User
Qtern 5 mg/10 mg film-coated tablets
saxagliptin/dapagliflozina
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Qtern contains the active substances saxagliptin and dapagliflozina. Both belong to a group of medicines called “oral antidiabetics”. These medicines are taken by mouth for diabetes.
Qtern is used to treat a type of diabetes called “type 2 diabetes mellitus” in adult patients (18 years or older). If you have type 2 diabetes, your pancreas does not produce enough insulin or your body is unable to use the insulin it produces properly. This results in a high level of sugar in the blood. The two active substances in Qtern work in two different ways to help control your blood sugar level and remove excess sugar from your body through urine.
Qtern is used to treat type 2 diabetes when:
It is important that you continue with the diet and exercise recommendations provided by your doctor, pharmacist, or nurse.
Do not take Qtern:
Do not take Qtern if you have any of the above conditions. If you are not sure, consult your doctor, pharmacist, or nurse before taking this medicine.
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to take Qtern and during treatment:
If you have any of the above conditions (or are unsure), consult your doctor, pharmacist, or nurse before taking Qtern.
Diabetic skin lesions (skin damage such as wounds or ulcers) are a common complication of diabetes. Skin rash has been observed with saxagliptin and dapagliflozina when given separately (see section 4). You are advised to follow the skin care recommendations provided by your doctor or nurse. Contact your doctor if you find blisters on your skin, as it may be a sign of a disease called bullous pemphigoid. Your doctor may ask you to stop taking Qtern.
As with all diabetic patients, it is important that you regularly check your feet and follow any other foot care advice provided by your healthcare professional.
Consult your doctor immediately if you experience a combination of symptoms of pain, tenderness, redness, or swelling of the genitals or the area between the genitals and anus, with fever or general feeling of being unwell. These symptoms could be a sign of a rare but serious, potentially life-threatening infection called necrotizing fasciitis of the perineum or Fournier's gangrene, which destroys tissue under the skin. Fournier's gangrene requires immediate treatment.
Kidney function
A review of kidney function should be performed before starting to take Qtern. During treatment with this medicine, your doctor will check your kidney function once a year or more frequently if your kidney function is worsening.
Urinalysis
Due to the way Qtern works, your urine will test positive for glucose while you are taking this medicine.
Children and adolescents
Qtern is not recommended for children and adolescents under 18 years of age, as it has not been studied in these patients.
Other medicines and Qtern
Taking Qtern with other medicines. Inform your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medicines.
Especially inform your doctor:
If you have any of the above conditions (or are unsure), consult your doctor before taking Qtern.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Qtern is not recommended during pregnancy, and if you become pregnant, your doctor will ask you to stop taking this medicine. Consult your doctor about the best way to control your blood sugar during pregnancy.
Do not use Qtern if you are breast-feeding. It is not known if this medicine passes into human breast milk. Consult your doctor if you wish to or are breast-feeding before taking this medicine.
Driving and using machines
Qtern is unlikely to affect your ability to drive or use tools or machines. If you feel dizzy while taking this medicine, do not drive or use tools or machines. Taking this medicine with another medicine that lowers blood sugar, such as sulfonylurea, may cause low blood sugar levels (hypoglycemia). This can cause symptoms such as shaking, sweating, and changes in vision that may affect your ability to drive or use machines.
Qtern contains lactose
Qtern contains lactose (milk sugar). If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Qtern contains sodium
Qtern contains less than 1 mmol of sodium (23 mg) per dose; this is essentially “sodium-free”.
Follow exactly the administration instructions of this medicine given by your doctor. If you are not sure, consult your doctor, pharmacist, or nurse again.
How much to take
How to take this medicine
Your doctor may prescribe other medicines to lower blood sugar. Remember to take this (these) other medicine(s) following your doctor's instructions. This will help you get the best results for your health.
Diet and exercise
To control your diabetes, you should continue with diet and exercise, even when taking this medicine. Therefore, it is important that you continue with the diet and exercise recommendations provided by your doctor, pharmacist, or nurse. In particular, if you follow a weight-control diet for diabetics, continue with it while taking Qtern.
If you take more Qtern than you should
If you take more Qtern tablets than you should, consult your doctor or go to the hospital immediately. Take the medicine package with you.
If you forget to take Qtern
What to do if you forget to take a tablet.
If you stop taking Qtern
Do not stop taking Qtern without first consulting your doctor. Your blood sugar levels may increase without this medicine.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Stop taking Qtern and consult a doctor immediately if you notice any of these serious adverse effects:
Your doctor may prescribe a medicine to treat your allergic reaction and a different medicine for your diabetes.
These are the signs of a severe urinary tract infection:
Although it is infrequent, if you notice blood in your urine, inform your doctor immediately.
The signs of low blood sugar are:
Your doctor will explain how to treat low blood sugar levels and what to do if you experience any of the above signs.
These are the signs of diabetic ketoacidosis (see also section 2 Warnings and precautions):
This can occur regardless of blood glucose levels. Your doctor must decide whether to temporarily or permanently interrupt your treatment with Qtern.
Stop taking Qtern and consult a doctor or nurse immediately, if you notice any of the above serious adverse effects.
Other adverse effects of treatment with Qtern alone or in combination with metformin:
Very common
Common
Uncommon
Rare
Unknown (frequency cannot be estimated from available data)
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the blister pack and carton after EXP/CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Composition of Qtern
Each tablet contains saxagliptin hydrochloride equivalent to 5 mg of saxagliptin and dapagliflozin propanediol monohydrate equivalent to 10 mg of dapagliflozin.
Appearance of the product and package contents
The film-coated Qtern 5 mg/10 mg tablets are light brown to brown, biconvex, round, 0.8 cm, film-coated. They are marked "5/10" on one side and "1122" on the other, in blue ink.
The Qtern 5 mg/10 mg tablets are available in aluminum blisters in pack sizes of 14, 28, or 98 film-coated tablets in calendar blisters and in packs of 30 film-coated tablets in blisters.
Not all pack sizes may be marketed in your country.
Marketing authorization holder
AstraZeneca AB
SE-151 85 Södertälje
Sweden
Manufacturer
AstraZeneca AB
Gärtunavägen
SE-152 57 Södertälje
Sweden
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
België/Belgique/Belgien AstraZeneca S.A./N.V. Tel: +32 2 370 48 11 | Lietuva UAB AstraZeneca Lietuva Tel: +370 5 2660550 |
Luxembourg/Luxemburg AstraZeneca S.A./N.V. Tél/Tel: +32 2 370 48 11 | |
Ceská republika AstraZeneca Czech Republic s.r.o. Tel: +420 222 807 111 | Magyarország AstraZeneca Kft. Tel.: +36 1 883 6500 |
Danmark AstraZeneca A/S Tlf.: +45 43 66 64 62 | Malta Associated Drug Co. Ltd Tel: +356 2277 8000 |
Deutschland AstraZeneca GmbH Tel: +49 40 809034100 | Nederland AstraZeneca BV Tel: +31 85 808 9900 |
Eesti AstraZeneca Tel: +372 6549 600 | Norge AstraZeneca AS Tlf: +47 21 00 64 00 |
Ελλάδα AstraZeneca A.E. Τηλ: +30 2 106871500 | Österreich AstraZeneca Österreich GmbH Tel: +43 1 711 31 0 |
España AstraZeneca Farmacéutica Spain, S.A. Tel: +34 91 301 91 00 | Polska AstraZeneca Pharma Poland Sp. z o.o. Tel.: +48 22 245 73 00 |
France AstraZeneca Tél: +33 1 41 29 40 00 | Portugal AstraZeneca Produtos Farmacêuticos, Lda. Tel: +351 21 434 61 00 |
Hrvatska AstraZeneca d.o.o. Tel: +385 1 4628 000 | România AstraZeneca Pharma SRL Tel: +40 21 317 60 41 |
Ireland AstraZeneca Pharmaceuticals (Ireland) DAC Tel: +353 1609 7100 | Slovenija AstraZeneca UK Limited Tel: +386 1 51 35 600 |
Ísland Vistor Sími: +354 535 7000 | Slovenská republika AstraZeneca AB, o.z. Tel: +421 2 5737 7777 |
Italia AstraZeneca S.p.A. Tel: +39 02 00704500 | Suomi/Finland AstraZeneca Oy Puh/Tel: +358 10 23 010 |
Κύπρος Αλέκτωρ Φαρμακευτική Λτδ Τηλ: +357 22490305 | Sverige AstraZeneca AB Tel: +46 8 553 26 000 |
Latvija SIA AstraZeneca Latvija Tel: +371 67377100 |
Date of the last revision of this leaflet:
Other sources of information
Detailed information about this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu/